| Bioactivity | Dyrk1A-IN-10 (compound B4) is a DYRK1A inhibitor with antidiabetic activity. Dyrk1A-IN-10 can promote pancreatic β-cell proliferation, increase insulin secretion, and lower blood sugar[1]. |
| CAS | 2891824-14-7 |
| Formula | C22H21ClN2O2 |
| Molar Mass | 380.87 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Li Guan, et al. "Design, synthesis, and biological evaluation of β-carboline-cinnamic acid derivatives as DYRK1A inhibitors in the treatment of diabetes." Bioorganic Chemistry (2024): 107676. |
Dyrk1A-IN-10
CAS: 2891824-14-7 F: C22H21ClN2O2 W: 380.87
Dyrk1A-IN-10 (compound B4) is a DYRK1A inhibitor with antidiabetic activity. Dyrk1A-IN-10 can promote pancreatic β-cell
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.